Author's Organization:Iatrochemical Institute of Pharmacological Research Foundation Iatrochemical Institute of Pharmacological Research Foundation Iatrochemical Institute of Pharmacological Research Foundation
1, 1-Bis(2-chloroethyl)hydrazine and its hydrazide- and hydrazone- type derivatives were prepared and investigated as to their chemical reactivity and anti-tumor activity against the Yoshida sarcoma.